Medindia

X

Website on Medical Education Launched By MSD In India

by Sasikala Radhakrishnan on  June 28, 2014 at 1:52 PM Corporate News   - G J E 4
A medical education website, Univadis, has been set up in India by MSD Pharmaceuticals Pvt Ltd, the Indian arm of US-based Merck & Co.
Website on Medical Education Launched By MSD In India
Website on Medical Education Launched By MSD In India
Advertisement

MSD, in collaboration with the Lancet, one of the leading global independent general medical journals, has launched this unique, interactive online medical education portal exclusively for Indian healthcare professionals.

Advertisement
The website will provide access to a plenty of medical resources and accredited education courses from reputed and independent sources.

The website, Univadis, has been launched in more than 40 countries and is available in 17 languages. It currently has more than 20 million registered users worldwide.

The online portal is available free of cost for healthcare professionals and does not display any product advertising.

K G Ananthakrishnan, managing director, MSD India, said, "We are proud to launch Univadis in India to aid comprehensive healthcare management, thereby making available unbiased, reliable scientific medical information across all parts of the country. Univadis portal provides high quality online education enabling healthcare practitioners to expand their knowledge and expertise and thereby offer better quality of care to their patients. MSD is known to be a trusted partner for continuous medical education across the globe and in India."

On strategic partnership with Univadis, Dr David Collingridge, publishing director for The Lancet's speciality journals the Lancet, said that it offers a unique opportunity to increase delivery of the best science to Indian doctors in a free and easily accessible format, which will help promote best clinical practice and health systems reform.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All